InfraReDx Announces TVC Imaging System to be Featured in Panels, Live Case Broadcasts and Plenary Session at EuroPCR 2012
5/10/2012 11:44:42 AM
BURLINGTON, Mass.--(BUSINESS WIRE)--Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, today announced that its TVC Imaging System™ for the true vessel characterization of coronary artery disease will be featured in panels, live case presentations and a plenary session at EuroPCR 2012, being held May 15-18, 2012 at the Palais des Congrès in Paris. The TVC Imaging System is a first-in-class intravascular imaging system with the unique ability to assess vessel composition and structure via integrated near infrared spectroscopy (NIRS) lipid core plaque (LCP) detection and enhanced intravascular ultrasound (IVUS) imaging technology. The TVC Imaging System is the only device available in both the U.S. and Europe for the detection of the LCPs known to complicate stenting and believed to be the reason for most heart attacks. Outside of the U.S., the TVC Imaging System is available in more than 30 countries worldwide.
comments powered by